Recent advances in the field of obesity treatment have generated a new therapy known as ALLUVI Retatrutide. This compound is a {highlyeffective GLP-1 receptor agonist, engineered to amplify the effects of natural glucagon-like peptide-1. Retatrutide has shown remarkable outcomes in clinical trials, highlighting significant decreases in body weight